Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-25-005004·Arcus Biosciences, Inc.
Schedule 13G ownership disclosure
Arcus Biosciences Inc
Common Stock, par value $0.0001 per share · CUSIP: 03969F109
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Point72 Asset Management, L.P.
Shares: 4,332,479.00 · Class: 4.1%
- Point72 Capital Advisors, Inc.
Shares: 4,332,479.00 · Class: 4.1%
- Steven A. Cohen
Shares: 4,332,479.00 · Class: 4.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-005004
- Form type
- SCHEDULE 13G/A
- Filer
- Arcus Biosciences, Inc.
- CIK
- CIK 1724521
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership